BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
Kotak maintains reduce on Torrent Pharma
Kotak has maintained 'reduce' rating on Torrent Pharma for target of Rs 1,320/share. Kotak expects that there will be pressure on profitability from FY'17. Expect cross currency headwinds and stock is currently trading at 25 times 2017 price to earnings ratio.